Wellington Management Group
KDNY

Wellington Management Group’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Wellington Management Group’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-56,703
Closed -$1.31M – 2072
2023
Q1 		$1.31M Sell
56,703
-890
-2% -$21.2K ﹤0.01% 1588
2022
Q4 		$1.51M Buy
57,593
+12,503
+28% +$277K ﹤0.01% 1561
2022
Q3 		$886K Sell
45,090
-1,326
-3% -$26.6K ﹤0.01% 1679
2022
Q2 		$812K Hold
46,416
– – ﹤0.01% 1713
2022
Q1 		$760K Buy
+46,416
New +$631K ﹤0.01% 1788
2019
Q1 		– Sell
-1,194,282
Closed -$15.8M – 2147
2018
Q4 		$15.8M Sell
1,194,282
-989,316
-45% -$19.8M ﹤0.01% 1056
2018
Q3 		$80.2M Sell
2,183,598
-11,526
-0.5% -$370K 0.02% 657
2018
Q2 		$76.8M Sell
2,195,124
-51,128
-2% -$1.96M 0.02% 663
2018
Q1 		$104M Buy
2,246,252
+135,699
+6% +$4.97M 0.02% 563
2017
Q4 		$79.1M Buy
2,110,553
+107,357
+5% +$4.69M 0.02% 645
2017
Q3 		$107M Buy
2,003,196
+68,192
+4% +$4.05M 0.02% 528
2017
Q2 		$110M Buy
1,935,004
+45,298
+2% +$2.27M 0.03% 477
2017
Q1 		$102M Buy
1,889,706
+158,354
+9% +$8.95M 0.02% 508
2016
Q4 		$98.7M Buy
1,731,352
+471,657
+37% +$28.5M 0.02% 505
2016
Q3 		$78.3M Buy
1,259,695
+950,578
+308% +$67.2M 0.02% 560
2016
Q2 		$17.5M Buy
+309,117
New +$18.8M ﹤0.01% 994

Other funds holding KDNY

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Wellington Management Group's KDNY Position: Q2 2023 in Review

Wellington Management Group sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q2 2023, closing a stake of 56,703 shares — an estimated $1.31M sold.

Wellington Management Group first reported a position in KDNY in Q2 2016 and held it in 16 quarters. The position peaked at $110M in Q2 2017. 185 funds tracked by Wall St. Rank hold KDNY as of Q2 2023.

  • Wellington Management Group reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Wellington Management Group sold 56,703 Chinook Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $1.31M.
  • Wellington Management Group first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2016 and held it in 16 quarters.
  • Wellington Management Group's Chinook Therapeutics, Inc. Common Stock position peaked at $110M in Q2 2017.
  • 185 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Wellington Management Group's 13F filing for Q2 2023, filed 14 Aug 2023.